Citations

Mayo Clinic

Showing 10 of 108599 citations.

Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence
Johnson, Margaret , Bell, April , Lauing, Kristen L. , Ladomersky, Erik , Zhai, Lijie , Penco-Campillo, Manon , Shah, Yajas , Mauer, Elizabeth , Xiu, Joanne , Drumm, Michael , Elemento, Olivier , Low, Justin , Memon, Ruba , Wu, Jennifer D. , Zhao, Junfei , Mi, Xinlei , Glantz, Michael , Sengupta, Soma , Walunas, Theresa L. , Schiltz, Gary E. , Lukas, Rimas V. , Nicolaides, Theodore , Drumm, Michael , McCortney, Kathleen , Elemento, Olivier , Kim, Miri , Bommi, Prashant , Low, Justin T , Memon, Ruba , Wu, Jennifer , Zhao, Junfei , Mi, Xinlei , Glantz, Michael J , Sengupta, Soma , Castro, Brandyn , Yamini, Bakhtiar , Horbinski, Craig , Baker, Darren J , Walunas, Theresa L , Schiltz, Gary E , Lukas, Rimas V , Wainwright, Derek A , Mauer, Elizabeth , Nicolaides, Theodore , McCortney, Kathleen , Kim, Miri , Bommi, Prashant V. , Horbinski, Craig , Baker, Darren J.

Clinical Cancer Research | September 19, 2023 | Volume: 29 | Issue: 23 | Pages: 4973-4989

10.1158/1078-0432.ccr-23-0834 | PMID 37725593 Get It

Abstract Purpose: Glioblastoma (GBM) is the most common aggressive primary malignant brain tumor in adults with a median age of onset of 68 to 70 years old. Although advanced age is often associated with poorer GBM patient survival, the predominant source(s) of maladaptive aging effects remains to be established. Here, we studied intratumoral and extratumoral relationships between adult patients with GBM and mice with brain tumors across the lifespan. Experimental Design: Electronic health records at Northwestern Medicine and the NCI SEER databases were evaluated for GBM patient age and overall survival. The commercial Tempus and Caris databases, as well as The Cancer Genome Atlas were profiled for gene expression, DNA methylation, and mutational changes with varying GBM patient age. In addition, gene expression analysis was performed on the extratumoral brain of younger and older adult mice with or without a brain tumor. The survival of young and old wild-type or transgenic (INK-ATTAC) mice with a brain tumor was evaluated after treatment with or without senolytics and/or immunotherapy. Results: Human patients with GBM ≥65 years of age had a significantly decreased survival compared with their younger counterparts. While the intra-GBM molecular profiles were similar between younger and older patients with GBM, non-tumor brain tissue had a significantly different gene expression profile between young and old mice with a brain tumor and the eradication of senescent cells improved immunotherapy-dependent survival of old but not young mice. Conclusions: This work suggests a potential benefit for combining senolytics with immunotherapy in older patients with GBM.
Interferon-independent processes constrain measles virus cell-to-cell spread in primary human airway epithelial cells
Durnell, Lorellin A. , Hippee, Camilla E. , Cattaneo, Roberto , Bartlett, Jennifer A. , Sinn, Patrick L , Singh, Brajesh K. , Sinn, Patrick L.

Microbiology Spectrum | September 19, 2023 | Volume: 11 | Issue: 5 | Pages: No page available

10.1128/spectrum.01361-23 | PMID 37724882 Get It

ABSTRACT Amplification of measles virus (MeV) in human airway epithelia may contribute to its extremely high contagious nature. We use well-differentiated primary cultures of human airway epithelial cells (HAE) to model ex vivo how MeV spreads in human airways. In HAE, MeV spreads cell-to-cell for 3–5 days, but then, infectious center growth is arrested. What stops MeV spread in HAE is not understood, but interferon (IFN) is known to slow MeV spread in other in vitro and in vivo models. Here, we assessed the role of type I and type III IFN in arresting MeV spread in HAE. The addition of IFN-β or IFN-λ1 to the medium of infected HAE slowed MeV infectious center growth, but when IFN receptor signaling was blocked, infectious center size was not affected. In contrast, blocking type-I IFN receptor signaling enhanced respiratory syncytial virus spread. HAE were also infected with MeV mutants defective for the V protein. The V protein has been demonstrated to interact with both MDA5 and STAT2 to inhibit activation of innate immunity; however, innate immune reactions were unexpectedly muted against the V-defective MeV in HAE. Minimal innate immunity activation was confirmed by deep sequencing, quantitative RT-PCR, and single-cell RNA-seq analyses of the transcription of IFN and IFN-stimulated genes. We conclude that in HAE, IFN-signaling can contribute to slowing infectious center growth; however, IFN-independent processes are most important for limiting cell-to-cell spread. Importance Fundamental biological questions remain about the highly contagious measles virus (MeV). MeV amplifies within airway epithelial cells before spreading to the next host. This final step likely contributes to the ability of MeV to spread host-to-host. Over the course of 3–5 days post-infection of airway epithelial cells, MeV spreads directly cell-to-cell and forms infectious centers. Infectious center formation is unique to MeV. In this study, we show that interferon (IFN) signaling does not explain why MeV cell-to-cell spread is ultimately impeded within the cell layer. The ability of MeV to spread cell-to-cell in airway cells without appreciable IFN induction may contribute to its highly contagious nature. This study contributes to the understanding of a significant global health concern by demonstrating that infectious center formation occurs independent of the simplest explanation for limiting viral transmission within a host.
Early antibody treatment, inflammation, and risk of post-COVID conditions
Heath, Sonya L. , Fukuta, Yuriko , Zhu, Xianming , Baksh, Sheriza , Abraham, Allison G., Habtehyimer, Feben , Shade, David , Ruff, Jessica E. , Ram, Malathi , Laeyendecker, Oliver , Fernández, Reinaldo E. , Patel, Eshan U. , Baker, Owen R. , Cachay, Edward R. , Gerber, Jonathan M. , Forthal, Donald N. , Hammitt, Laura L. , Huamán, Moisés A. , Patel, Bela , Gniadek, Thomas J. , Blair, Janis E. , Lane, Karen , McBee, Nichol , Gawad, Amy L., Das, Piyali, Bloch, Evan M. , Zhu, Xianming , Laeyendecker, Oliver , Patel, Eshan U , Forthal, Donald N , Sutcliffe, Catherine G , Klein, Sabra L , Pekosz, Andrew , Bloch, Evan M , Casadevall, Arturo , Tobian, Aaron A R , Sullivan, David J , Huaman, Moises A , Gebo, Kelly A , Shoham, Shmuel , Currier, Judith S. , Meisenberg, Barry R. , Levine, Adam C , Mosnaim, Giselle S , Paxton, James H , Raval, Jay S. , Anjan, Shweta , Kassaye, Seble , Hanley, Daniel F. , Casadevall, Arturo , Tobian, Aaron A.R. , Sullivan, David

mBio | September 19, 2023 | Volume: 14 | Issue: 5 | Pages: No page available

10.1128/mbio.00618-23 | PMID 37724870 Get It

Post-COVID conditions (PCCs) are common and have significant morbidity. Risk factors for PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about treatment, inflammation, and PCC. Among 882 individuals with confirmed SARS-CoV-2 infection participating in a randomized trial of COVID-19 convalescent plasma (CCP) vs control plasma with available biospecimens and symptom data, the association between early CCP treatment, cytokine levels, and PCC was evaluated. Cytokine and chemokine levels were assessed at baseline, day 14, and day 90 using a multiplexed sandwich immunoassay (Meso Scale Discovery). Presence of any self-reported PCC symptoms was assessed at day 90. Associations between CCP treatment, cytokine levels, and PCC were examined using multivariate logistic regression models. One third of the 882 participants had day 90 PCC symptoms, with fatigue (14.5%) and anosmia (14.5%) being most common. Cytokine levels decreased from baseline to day 90. In a multivariable analysis, female sex (adjusted odds ratio [AOR] = 2.69 [1.93–3.81]), older age (AOR = 1.32 [1.17–1.50]), and elevated baseline levels of IL-6 (AOR = 1.59 [1.02–2.47]) were independently associated with development of PCC. Those who received early CCP treatment (≤5 days after symptom onset) compared to late CCP treatment had statistically significant lower odds of PCC. IMPORTANCE Approximately 20% of individuals infected with SARS-CoV-2 experienced long-term health effects, as defined PCC. However, it is unknown if there are any early biomarkers associated with PCC or whether early intervention treatments may decrease the risk of PCC. In a secondary analysis of a randomized clinical trial, this study demonstrates that among outpatients with SARS-CoV-2, increased IL-6 at time of infection is associated with increased odds of PCC. In addition, among individuals treated early, within 5 days of symptom onset, with COVID-19 convalescent plasma, there was a trend for decreased odds of PCC after adjusting for other demographic and clinical characteristics. Future treatment studies should be considered to evaluate the effect of early treatment and anti-IL-6 therapies on PCC development.
Episodic Cocaine Use as a Cause of Venous Thromboembolism and Acute Liver Injury
Patel, Khyati H., Thomas, Kyle C., Stacey, Stephen K , Thomas, Kyle

American Journal of Case Reports | September 19, 2023 | Volume: 24 | Issue: No issue available | Pages: No page available

10.12659/ajcr.941360 | PMID 37872733 Get It

A bibliometric analysis of publications in Renal Failure in the last three decades
Ho, Yuh‐Shan , Tapolyai, Mihály , Cheungpasitporn, Wisit , Fülöp, Tibor , Cheungpasitporn, Wisit , Tapolyai, Mihaly , Fülöp, Tibor

Renal Failure | September 19, 2023 | Volume: 45 | Issue: 2 | Pages: No page available

10.1080/0886022x.2023.2241913 | PMID 37724541 Get It

Reimagining the Rheumatology Fellowship Interview: Using Participatory Design‐Thinking Process to Create a More Applicant‐Centered Experience
Kumar, Bharat , Feng, Alick, Gheriani, Gatr-Alnada, Iftekhar, Ayesha, Ni, Ruoning , Dimachkie, Mohamad Dave , Gokalp, Gizem, Bazigh, Izza, Moy, Lindsay, Chen, Chao , Lingamaneni, Ankitha, Patel, Axi, Cepero, Gretchen Santana , Iqtidar, Tariq, Thoene, Patricia Bruffey, Knaack, Aaron, Swee, Melissa L. , Suneja, Manish , Gokalp, Gizem, Moy, Lindsay N , Davis, Benjamin P.

ACR Open Rheumatology | September 19, 2023 | Volume: 5 | Issue: 11 | Pages: 600-608

10.1002/acr2.11606 | PMID 37724836 Get It

ObjectiveDesign thinking is a creative problem‐solving process used to better understand users’ needs and experiences so that a product or service can be improved. Its emphasis on empathy, iterative prototyping, and participatory collaboration make it an ideal methodology for innovation in medical education. We apply this framework to the virtual rheumatology fellowship interview process so that interviews can become more applicant centered.MethodsThis educational quality improvement project uses a design‐thinking framework to identify opportunities and challenges for rheumatology fellowship applicants. The investigators use the 5‐step process (Empathize, Define, Ideate, Prototype, Test) and incorporate rapid qualitative analysis of semistructured interviews to innovate the interview experience. The iterative and collaborative nature of this process has empowered participants to codesign an applicant‐centered interview experience.ResultsInterviews with fellowship applicants (n = 9), fellow physicians (n = 4), and faculty members (n = 3) identified three major dynamics of the interview process: (1) Is it a safe environment to ask questions? (2) How do I exchange information effectively? and (3) How do I fit all these data into the bigger picture? Creative brainstorming techniques at a series of three workshops yielded four prototypes emphasizing customization, hybridization, facilitation, and preparation. A finalized applicant‐centered interview template was devised in preparation for the 2023‐2024 application season.ConclusionDesign thinking has yielded insights into three important dynamics that drive applicant experiences. These insights allow for a redesign of processes so that virtual interviews can be more applicant centered. This framework allows for further iterations and modifications as the needs of applicants and programs evolve over time.
Arthroscopic Lysis of Adhesions for Arthrofibrosis After Anterior Cruciate Ligament Reconstruction
Lamba, Abhinav , Holliday, Charles L. , Reinholz, Anna K., Wilbur, Ryan R. , Song, Bryant M. , Krych, Aaron J. , Stuart, Michael J. , Levy, Bruce A. , Marigi, Erick M. , Krych, Aaron J , Stuart, Michael J , Lamba, Abhinav , Hevesi, Mario

The American Journal of Sports Medicine | September 19, 2023 | Volume: 51 | Issue: 12 | Pages: 3149-3153

10.1177/03635465231195366 | PMID 37724743 Get It

Background: Arthrofibrosis (AF) after anterior cruciate ligament reconstruction (ACLR) remains a challenge. There is a paucity of data on arthroscopic interventions for AF after ACLR. Purpose: To (1) describe the patient, injury, and surgical characteristics and patient-reported outcomes (PROs) of those requiring an arthroscopic intervention for loss of motion after ACLR and (2) compare outcomes between patients undergoing an early intervention (within 3 months) versus those undergoing a late intervention (after 3 months). Study Design: Case series; Level of evidence, 4. Methods: Patients with a history of ACLR and a subsequent operative procedure for postoperative AF at a single institution between 2000 and 2018 were retrospectively identified. Arthroscopic interventions included lysis of adhesions, capsular release with or without manipulation under anesthesia, and excision of cyclops lesions. Patients were excluded if they had a knee dislocation or multiple-ligament injury, a periarticular fracture, or less than 2-year follow-up from the arthroscopic intervention. PROs including the Tegner activity score, visual analog scale pain score, and International Knee Documentation Committee score as well as knee range of motion (ROM) were recorded. Results: A total of 40 patients were included with a mean age of 27.2 years (range, 11.0-63.8 years) at surgery and a mean follow-up of 10.0 years (range, 2.9-20.7 years). The mean preoperative flexion and extension were 102° (range, 40°-150°) and 8° (range, 0°-25°), respectively. The mean postoperative flexion and extension were 131° (range, 110° to 150°) and 0° (range, –10° to 5°), respectively. After the arthroscopic intervention, the mean ROM improved from 94° (range, 40°-140°) preoperatively to 131° (range, 107°-152°) at final follow-up ( P < .001), and the visual analog scale pain score improved from 3.0 preoperatively to 1.2 postoperatively ( P = .001). Overall, 13 patients (32.5%) underwent an intervention within 3 months and 27 (67.5%) after 3 months. The early intervention group had a higher postoperative International Knee Documentation Committee score compared with the late intervention group (86.8 vs 71.7, respectively; P = .035). Conclusion: An arthroscopic intervention for AF after ACLR successfully improved knee ROM and pain. Patients who underwent either early or late surgery obtained satisfactory motion and function, although improved PROs were observed when the intervention occurred within 3 months of the primary procedure.
Outcomes of revision versus re-revision reverse total shoulder arthroplasty: A case–control-matched cohort study
O’Keefe, Daniel S. , Teurlings, Tyler , Hao, Kévin A. , Saengchote, Supreeya A. , Wright, Thomas W. , Struk, Aimee M., King, Joseph J. , S O'Keefe, Daniel , Teurlings, Tyler L , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Schoch, Bradley S. , Farmer, Kevin W.

Shoulder & Elbow | September 19, 2023 | Volume: 16 | Issue: 5 | Pages: 543-550

10.1177/17585732231202214 | PMID 39473473 Get It

Background The increasing incidence of reverse total shoulder arthroplasties (RTSA) has led to an increase in revision surgery. We aimed to compare patients undergoing re-revision RTSA to a matched cohort undergoing first-revision RTSA. Methods A retrospective review of all revision RTSAs was performed at a single institution. Sixteen shoulders that underwent re-revision RTSA were matched 1:3 to shoulders that underwent revision RTSA with a minimum two-year follow-up. Outcome scores including the American Shoulder and Elbow Surgeons Shoulder Score (ASES), Short-Form 12 (SF-12), Shoulder Pain and Disability Index (SPADI), and Simple Shoulder Test (SST) scores, range of motion (ROM), and improvement from preoperative to postoperative outcomes after re-revision RTSA were assessed. Additionally, postoperative outcomes after re-revision RTSA were compared to patients that underwent first revision RTSA and subsequently compared to the minimal clinically important difference (MCID) values for the outcome scores and ROM measurements assessed. Results Sixteen shoulders that underwent re-revision RTSA and 78 revision RTSAs met the final inclusion criteria to be included in this study. Significant improvement from preoperative to postoperative re-revision RTSA was seen in the ASES score (p = 0.046), SPADI score (p = 0.044), SST (p = 0.008), abduction (p = 0.016), and elevation (p = 0.025), but not the SF-12 score (p = 0.396), external rotation (p = 0.449), or internal rotation (p = 0.451). Outcomes after revision RTSA were found to be superior to outcomes after re-revision RTSA for all outcome scores (ASES p = 0.029, SF-12 p = 0.018, SPADI p = 0.003) except the SST score (p = 0.080) and all ROM measures (p > 0.05 for all). Internal rotation was equivalent postoperatively between both groups. From preoperative to postoperative re-revision RTSA, the mean improvement exceeded the MCID for the SST score, abduction, forward elevation, and external rotation. When comparing postoperative revision RTSA to postoperative re-revision RTSA, the mean difference between revision and re-revision RTSA exceeded the MCID for the SPADI score and external rotation. The complication rate was 19% in shoulders undergoing first revision and 41% in shoulders undergoing re-revision RTSA. Conclusion Patients undergoing re-revision RTSA receive improvement in clinical outcomes, but do not achieve outcomes comparable to those achieved after first revision RTSA.
Humanizing the Intensive Care Unit: Perspectives of Patients and Families on the Get to Know Me Board
Ahmad, Sumera , Rhudy, Lori M. , Fogelson, Lindsay A., Barwise, Amelia , Gajić, Ognjen, Karnatovskaia, Lioudmila V. , Ahmad, Sumera R , Barwise, Amelia K , LeMahieu, Allison , Gajic, Ognjen

Journal of Patient Experience | September 19, 2023 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/23743735231201228 | PMID 37736130 Get It

In this qualitative study, we explored perspectives of patients in the intensive care unit (ICU) and their families on the Get to Know Me board (GTKMB). Of the 46 patients approached, 38 consented to participate. Of the 66 family members approached, 60 consented to participate. Most patients (26, 89%) and family members (52, 99%) expressed that GTKMB was important in recognizing patient's humanity. Most patients (20, 68%) and families (39, 74%) said that it helped to build a better relationship with the provider team. 60% of patients and families commented that the GTKMB was used as a platform by providers to interact with them. Up to 45 (85%) of the family members supported specific contents of the GTKMB. In structured interviews (11 patients, 7 family members), participants additionally commented on ways providers used the GTKMB to communicate, support patient's personhood, and on caveats in interacting with GTKMB. Critically ill patients and families found the GTKMB helpful in preserving personhood of patient, fostering communication, and building relationships with clinicians.
Recent Advancements in Glaucoma Surgery—A Review
Ang, Bryan Chin Hou , Lim, Sheng Yang , Stewart, Michael W., Dorairaj, Syril , Ang, Bryan C H , Betzler, Bjorn Kaijun , Wong, Hon Jen

Bioengineering | September 19, 2023 | Volume: 10 | Issue: 9 | Pages: 1096

10.3390/bioengineering10091096 | PMID 37760198 Get It

Surgery has long been an important treatment for limiting optic nerve damage and minimising visual loss in patients with glaucoma. Numerous improvements, modifications, and innovations in glaucoma surgery over recent decades have improved surgical safety, and have led to earlier and more frequent surgical intervention in glaucoma patients at risk of vision loss. This review summarises the latest advancements in trabeculectomy surgery, glaucoma drainage device (GDD) implantation, and minimally invasive glaucoma surgery (MIGS). A comprehensive search of MEDLINE, EMBASE, and CENTRAL databases, alongside subsequent hand searches—limited to the past 10 years for trabeculectomy and GDDs, and the past 5 years for MIGS—yielded 2283 results, 58 of which were included in the final review (8 trabeculectomy, 27 GDD, and 23 MIGS). Advancements in trabeculectomy are described in terms of adjunctive incisions, Tenon’s layer management, and novel suturing techniques. Advancements in GDD implantation pertain to modifications of surgical techniques and devices, novel methods to deal with postoperative complications and surgical failure, and the invention of new GDDs. Finally, the popularity of MIGS has recently promoted modifications to current surgical techniques and the development of novel MIGS devices.